Schedule a Call Back
Lupin’s ESG score rises to 76 in S&P Global ESG Ratings
Industry News- Nov 25,24
A strong sustainability framework is at the heart of Lupin’s strategy and the company has integrated it in all its business operations.
Global pharma major Lupin Limited (Lupin) announced its S&P Global ESG scores have moved up to 76 from 69 last year, well above the industry average of 30 in the pharmaceuticals sector. The company has demonstrated consistent and sustained growth in its Environment, Social and Governance (ESG) performance, underlying its commitment to all aspects of business. Lupin’s steady climb in the S&P Global ESG scores is one amongst the fastest in the pharma industry in India.
A strong sustainability framework is at the heart of Lupin’s strategy and the company has integrated it in all its business operations. By accelerating its transition to net-zero emissions, enhancing social impact, and upholding the highest standards of governance, Lupin is paving the way for a more sustainable and equitable future.
Ramesh Swaminathan, Executive Director, Global CFO and Head – API Plus SBU, Lupin said, “We have made significant progress in our Environmental, Social, and Governance goals over the last four years. The S&P score reaffirms our commitment to prioritising sustainability and creating impactful and sustainable healthcare solutions that benefit our patients and our communities worldwide.”
Some of Lupin’s main focus areas on the ESG front are environmental stewardship (climate change, water recycling, circular economy, LCA, biodiversity assessment), employee well-being (diversity, equity and inclusion), supply chain sustainability, and patient-centric innovation. The Company has increased its share of use of renewable energy to 33.8% and reduced carbon emissions by 21% over the last year. The company is water positive in all its water usage.
Related Stories
Process Equipment
Lupin’s ESG score rises to 76 in S&P Global ESG Ratings
A strong sustainability framework is at the heart of Lupin’s strategy and the company has integrated it in all its business operations.
Read moreProcess Equipment
Trump 2.0 may boost Indian pharma opportunities
Experts highlight that higher tariffs on Chinese goods might enable Indian firms to fill supply gaps in the US generic drug market, a critical region that accounts for 30% of Indian pharma sales and..
Read moreProcess Equipment
AptarGroup breaks ground on new pharma plant in Taloja, near Mumbai
Spanning 4,400 square metres, the new plant will be constructed adjacent to Aptar's existing Mumbai facility, which opened in 2023.
Read moreRelated Products
Programmable Controllers - Pcd-33a Series
CHEMICAL PROCESS, FOOD/PHARMA EQUIPMENT & ANALYTICAL INSTRUMENTS
Pro-Med Instruments (P) Ltd offers a wide range of programmable controllers - PCD-33A Series.
Gasket Graphite Powder
CHEMICAL PROCESS, FOOD/PHARMA EQUIPMENT & ANALYTICAL INSTRUMENTS
Arihant Packing & Gasket Company offers a wide range of gasket graphite powder.
Asahi Kasei expands 3D printing filament sales in North America
CHEMICAL PROCESS, FOOD/PHARMA EQUIPMENT & ANALYTICAL INSTRUMENTS
Asahi Kasei, a leading resin and compounding technology provider, has initiated the sales of 3D printing (3DP) filaments in North America through Asahi Kasei Plastics North America (APNA). The soft la Read more
latest News
Subscribe to iNoW
For Industry News on WhatsApp, Give a Miss Call on: +91 84228 74016
